Skip to main content
Top
Gepubliceerd in: Quality of Life Research 9/2013

01-11-2013

Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy

Auteurs: Qiuling Shi, Tito R. Mendoza, G. Brandon Gunn, Xin Shelley Wang, David I. Rosenthal, Charles S. Cleeland

Gepubliceerd in: Quality of Life Research | Uitgave 9/2013

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

Treatment-related symptom burden varies significantly among patients undergoing radiotherapy or chemoradiotherapy, yet such variation is typically not reflected in the results from single-group studies. We applied group-based trajectory modeling (GBTM) to describe the heterogeneity of symptom burden among patients with head and neck cancer and to identify subgroups with distinct symptom-development trajectories.

Methods

Patients (n = 130) were recruited pretherapy and rated multiple symptoms weekly for 10 weeks via the M. D. Anderson Symptom Inventory. With the mean of five most severe symptoms over time as an outcome measure, GBTM was used to identify patient subgroups with distinct symptom trajectories. Linear mixed-effects modeling (LMM) was applied to compare with GBTM’s ability to describe the longitudinal symptom data.

Results

The five most severe symptoms were problems with taste, difficulty swallowing or chewing, problems with mucus, fatigue, and dry mouth. A two-group GBTM model identified 68 % of patients as having high symptom burden, associated with older age, worse baseline performance status, and chemoradiotherapy treatment. A four-group GBTM model generated one stable group (4 % of patients) and three groups varying in symptom severity with both linear and quadratic functions over time. LMM revealed symptom-change patterns similar to that produced by GBTM but was inferior in identifying risk factors for high symptom burden.

Conclusions

For cancer patients undergoing aggressive therapy, GBTM is capable of identifying various symptom-burden trajectories and provides severity groupings that will aid research and may be of clinical utility. These results may be generalizable to other cancer types and treatments.
Literatuur
1.
go back to reference Haigentz, M, Jr, Corry, J., Strojan, P., & Ferlito, A. (2012). Easing acceleration of head and neck chemoradiotherapy. Lancet Oncology, 13(2), 113–115.PubMedCrossRef Haigentz, M, Jr, Corry, J., Strojan, P., & Ferlito, A. (2012). Easing acceleration of head and neck chemoradiotherapy. Lancet Oncology, 13(2), 113–115.PubMedCrossRef
2.
go back to reference Rosenthal, D. I., Mendoza, T., & Cleeland, C. (2009). Identifying head and neck patients at risk for high symptom burden during treatment [abstract]. American society of clinical oncology 2009 annual meeting, Orlando, FL, May 29–Jun 2, 2009. Journal of Clinical Oncology, 27(15 Suppl). Abstract #6066. Rosenthal, D. I., Mendoza, T., & Cleeland, C. (2009). Identifying head and neck patients at risk for high symptom burden during treatment [abstract]. American society of clinical oncology 2009 annual meeting, Orlando, FL, May 29–Jun 2, 2009. Journal of Clinical Oncology, 27(15 Suppl). Abstract #6066.
3.
go back to reference Dodd, M. J., Cho, M. H., Cooper, B. A., & Miaskowski, C. (2010). The effect of symptom clusters on functional status and quality of life in women with breast cancer. European Journal of Oncology Nursing, 14(2), 101–110.PubMedCrossRef Dodd, M. J., Cho, M. H., Cooper, B. A., & Miaskowski, C. (2010). The effect of symptom clusters on functional status and quality of life in women with breast cancer. European Journal of Oncology Nursing, 14(2), 101–110.PubMedCrossRef
4.
go back to reference Miaskowski, C., Cooper, B. A., Paul, S. M., Dodd, M., Lee, K., Aouizerat, B. E., et al. (2006). Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis. Oncology Nursing Forum, 33(5), E79–E89.PubMedCrossRef Miaskowski, C., Cooper, B. A., Paul, S. M., Dodd, M., Lee, K., Aouizerat, B. E., et al. (2006). Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis. Oncology Nursing Forum, 33(5), E79–E89.PubMedCrossRef
5.
go back to reference Shi, Q., Smith, T. G., Michonski, J. D., Stein, K. D., Kaw, C., & Cleeland, C. S. (2011). Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society’s Studies of Cancer Survivors. Cancer, 117(12), 2779–2790.PubMedCrossRef Shi, Q., Smith, T. G., Michonski, J. D., Stein, K. D., Kaw, C., & Cleeland, C. S. (2011). Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society’s Studies of Cancer Survivors. Cancer, 117(12), 2779–2790.PubMedCrossRef
6.
go back to reference Nylund, K., Bellmore, A., Nishina, A., & Graham, S. (2007). Subtypes, severity, and structural stability of peer victimization: what does latent class analysis say? Child Development, 78(6), 1706–1722.PubMedCrossRef Nylund, K., Bellmore, A., Nishina, A., & Graham, S. (2007). Subtypes, severity, and structural stability of peer victimization: what does latent class analysis say? Child Development, 78(6), 1706–1722.PubMedCrossRef
7.
go back to reference Dodd, M. J., Cho, M. H., Cooper, B. A., Petersen, J., Bank, K. A., Lee, K. A., et al. (2011). Identification of latent classes in patients who are receiving biotherapy based on symptom experience and its effect on functional status and quality of life. Oncology Nursing Forum, 38(1), 33–42.PubMedCrossRef Dodd, M. J., Cho, M. H., Cooper, B. A., Petersen, J., Bank, K. A., Lee, K. A., et al. (2011). Identification of latent classes in patients who are receiving biotherapy based on symptom experience and its effect on functional status and quality of life. Oncology Nursing Forum, 38(1), 33–42.PubMedCrossRef
8.
go back to reference Wang, X. S., Fairclough, D. L., Liao, Z., Komaki, R., Chang, J. Y., Mobley, G. M., et al. (2006). Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms. Journal of Clinical Oncology, 24(27), 4485–4491.PubMedCrossRef Wang, X. S., Fairclough, D. L., Liao, Z., Komaki, R., Chang, J. Y., Mobley, G. M., et al. (2006). Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms. Journal of Clinical Oncology, 24(27), 4485–4491.PubMedCrossRef
9.
go back to reference Langford, D. J., Tripathy, D., Paul, S. M., West, C., Dodd, M. J., Schumacher, K., et al. (2011). Trajectories of pain and analgesics in oncology outpatients with metastatic bone pain. Journal of pain, 12(4), 495–507.PubMedCrossRef Langford, D. J., Tripathy, D., Paul, S. M., West, C., Dodd, M. J., Schumacher, K., et al. (2011). Trajectories of pain and analgesics in oncology outpatients with metastatic bone pain. Journal of pain, 12(4), 495–507.PubMedCrossRef
10.
go back to reference Merriman, J. D., Jansen, C., Koetters, T., West, C., Dodd, M., Lee, K., et al. (2010). Predictors of the trajectories of self-reported attentional fatigue in women with breast cancer undergoing radiation therapy. Oncology Nursing Society, 37(4), 423–432. Merriman, J. D., Jansen, C., Koetters, T., West, C., Dodd, M., Lee, K., et al. (2010). Predictors of the trajectories of self-reported attentional fatigue in women with breast cancer undergoing radiation therapy. Oncology Nursing Society, 37(4), 423–432.
11.
go back to reference Klepstad, P., Dale, O., Kaasa, S., Zahlsen, K., Aamo, T., Fayers, P., et al. (2003). Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients. Acta Anaesthesiologica Scandinavica, 47(6), 725–731.PubMedCrossRef Klepstad, P., Dale, O., Kaasa, S., Zahlsen, K., Aamo, T., Fayers, P., et al. (2003). Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients. Acta Anaesthesiologica Scandinavica, 47(6), 725–731.PubMedCrossRef
12.
go back to reference Nagin, D. S. (2005). Group-based modeling of development. Cambridge, MA: Harvard University Press. Nagin, D. S. (2005). Group-based modeling of development. Cambridge, MA: Harvard University Press.
13.
go back to reference Nagin, D. S., & Tremblay, R. E. (2001). Analyzing developmental trajectories of distinct but related behaviors: a group-based method. Psychological Methods, 6(1), 18–34.PubMedCrossRef Nagin, D. S., & Tremblay, R. E. (2001). Analyzing developmental trajectories of distinct but related behaviors: a group-based method. Psychological Methods, 6(1), 18–34.PubMedCrossRef
14.
go back to reference Brame, B., Nagin, D. S., & Tremblay, R. E. (2001). Developmental trajectories of physical aggression from school entry to late adolescence. Journal of Child Psychology and Psychiatry, 42(4), 503–512.PubMedCrossRef Brame, B., Nagin, D. S., & Tremblay, R. E. (2001). Developmental trajectories of physical aggression from school entry to late adolescence. Journal of Child Psychology and Psychiatry, 42(4), 503–512.PubMedCrossRef
15.
go back to reference Côté, S. M., Boivin, M., Liu, X., Nagin, D. S., Zoccolillo, M., & Tremblay, R. E. (2009). Depression and anxiety symptoms: onset, developmental course and risk factors during early childhood. Journal of Child Psychology and Psychiatry, 50(10), 1201–1208.PubMedCrossRef Côté, S. M., Boivin, M., Liu, X., Nagin, D. S., Zoccolillo, M., & Tremblay, R. E. (2009). Depression and anxiety symptoms: onset, developmental course and risk factors during early childhood. Journal of Child Psychology and Psychiatry, 50(10), 1201–1208.PubMedCrossRef
16.
go back to reference Modi, A. C., Cassedy, A. E., Quittner, A. L., Accurso, F., Sontag, M., Koenig, J. M., et al. (2010). Trajectories of adherence to airway clearance therapy for patients with cystic fibrosis. Journal of Pediatric Psychology, 35(9), 1028–1037. Modi, A. C., Cassedy, A. E., Quittner, A. L., Accurso, F., Sontag, M., Koenig, J. M., et al. (2010). Trajectories of adherence to airway clearance therapy for patients with cystic fibrosis. Journal of Pediatric Psychology, 35(9), 1028–1037.
17.
go back to reference Cleeland, C. S., Mendoza, T. R., Wang, X. S., Woodruff, J. F., Palos, G. R., Richman, S. P., et al. (2011). Levels of symptom burden during chemotherapy for advanced lung cancer: differences between public hospitals and a tertiary cancer center. Journal of Clinical Oncology, 29(21), 2859–2865.PubMedCrossRef Cleeland, C. S., Mendoza, T. R., Wang, X. S., Woodruff, J. F., Palos, G. R., Richman, S. P., et al. (2011). Levels of symptom burden during chemotherapy for advanced lung cancer: differences between public hospitals and a tertiary cancer center. Journal of Clinical Oncology, 29(21), 2859–2865.PubMedCrossRef
18.
go back to reference Rosenthal, D. I., Asper, J. A., Barker, J. L, Jr, Garden, A. S., Chao, K. S., Morrison, W. H., et al. (2006). Importance of patient examination to clinical quality assurance in head and neck radiation oncology. Head and Neck, 28(11), 967–973.PubMedCrossRef Rosenthal, D. I., Asper, J. A., Barker, J. L, Jr, Garden, A. S., Chao, K. S., Morrison, W. H., et al. (2006). Importance of patient examination to clinical quality assurance in head and neck radiation oncology. Head and Neck, 28(11), 967–973.PubMedCrossRef
19.
go back to reference Cleeland, C. S., Mendoza, T. R., Wang, X. S., Chou, C., Harle, M. T., Morrissey, M., et al. (2000). Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer, 89(7), 1634–1646.PubMedCrossRef Cleeland, C. S., Mendoza, T. R., Wang, X. S., Chou, C., Harle, M. T., Morrissey, M., et al. (2000). Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer, 89(7), 1634–1646.PubMedCrossRef
20.
go back to reference Rosenthal, D. I., Mendoza, T. R., Chambers, M. S., Asper, J. A., Gning, I., Kies, M. S., et al. (2007). Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head and Neck, 29(10), 923–931.PubMedCrossRef Rosenthal, D. I., Mendoza, T. R., Chambers, M. S., Asper, J. A., Gning, I., Kies, M. S., et al. (2007). Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head and Neck, 29(10), 923–931.PubMedCrossRef
22.
go back to reference Lo, Y. T., Mendell, N. R., & Rubin, D. B. (2001). Testing the number of components in a normal mixture. Biometrika, 88(3), 767–778.CrossRef Lo, Y. T., Mendell, N. R., & Rubin, D. B. (2001). Testing the number of components in a normal mixture. Biometrika, 88(3), 767–778.CrossRef
23.
go back to reference Rosenthal, D. I., Mendoza, T. R., Chambers, M. S., Burkett, V. S., Garden, A. S., Hessell, A. C., et al. (2008). The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis. International Journal of Radiation Oncology Biology Physics, 72(5), 1355–1361.CrossRef Rosenthal, D. I., Mendoza, T. R., Chambers, M. S., Burkett, V. S., Garden, A. S., Hessell, A. C., et al. (2008). The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis. International Journal of Radiation Oncology Biology Physics, 72(5), 1355–1361.CrossRef
24.
go back to reference Budach, W., Hehr, T., Budach, V., Belka, C., & Dietz, K. (2006). A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer, 6, 28.PubMedCrossRef Budach, W., Hehr, T., Budach, V., Belka, C., & Dietz, K. (2006). A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer, 6, 28.PubMedCrossRef
25.
go back to reference Muthén, B. (2003). Statistical and substantive checking in growth mixture modeling: Comment on Bauer and Curran (2003). Psychological Methods, 8(3), 369–377.PubMedCrossRef Muthén, B. (2003). Statistical and substantive checking in growth mixture modeling: Comment on Bauer and Curran (2003). Psychological Methods, 8(3), 369–377.PubMedCrossRef
26.
go back to reference Muthén, B. (2004). Latent variable analysis: growth mixture modeling and related techeniques for longitudinal data. In D. Kaplan (Ed.), The SAGE handbook of quantitative methodology for the social sciences (pp. 345–368). Thousand Oaks, CA: Sage Publications, Inc. Muthén, B. (2004). Latent variable analysis: growth mixture modeling and related techeniques for longitudinal data. In D. Kaplan (Ed.), The SAGE handbook of quantitative methodology for the social sciences (pp. 345–368). Thousand Oaks, CA: Sage Publications, Inc.
27.
go back to reference Tarpey, T., Yun, D., & Petkova, E. (2008). Model misspecification: finite mixture or homogeneous? Statistical Modelling, 8(2), 199–218.PubMedCrossRef Tarpey, T., Yun, D., & Petkova, E. (2008). Model misspecification: finite mixture or homogeneous? Statistical Modelling, 8(2), 199–218.PubMedCrossRef
28.
go back to reference Bauer, D. J., & Curran, P. J. (2003). Distributional assumptions of growth mixture models: Implications for overextraction of latent trajectory classes. Psychological Methods, 8(3), 338–363.PubMedCrossRef Bauer, D. J., & Curran, P. J. (2003). Distributional assumptions of growth mixture models: Implications for overextraction of latent trajectory classes. Psychological Methods, 8(3), 338–363.PubMedCrossRef
Metagegevens
Titel
Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy
Auteurs
Qiuling Shi
Tito R. Mendoza
G. Brandon Gunn
Xin Shelley Wang
David I. Rosenthal
Charles S. Cleeland
Publicatiedatum
01-11-2013
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 9/2013
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-013-0380-2

Andere artikelen Uitgave 9/2013

Quality of Life Research 9/2013 Naar de uitgave